Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,965,251
-
Share change
-
+19,965,251
-
Total reported value
-
$454,425,000
-
Price per share
-
$22.83
-
Number of holders
-
17
-
Value change
-
+$454,424,870
-
Number of buys
-
17
Institutional Holders of Jade Biosciences, Inc. - COM (AVTE) as of Q2 2021
As of 30 Jun 2021,
Jade Biosciences, Inc. - COM (AVTE) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,965,251 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Sofinnova Investments, Inc., Cormorant Asset Management, LP, CITADEL ADVISORS LLC, BAKER BROS. ADVISORS LP, FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ORBIMED ADVISORS LLC, Sectoral Asset Management Inc, and GOLDMAN SACHS GROUP INC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.